Back
Nurix Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66
NRIX
Nurix Therapeutics
Last Price:
$12.15
Seasonality Move:
1.4%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NRIX is experiencing slight buying pressure.
Nurix Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.59 | Buy |
20-day SMA: | 12.06 | Buy |
50-day SMA: | 11.26 | Buy |
200-day SMA: | 16.95 | Sell |
8-day EMA: | 9.04 | Buy |
20-day EMA: | 4.98 | Buy |
50-day EMA: | 2.29 | Buy |
200-day EMA: | 0.62 | Buy |
Nurix Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.12 | Buy |
Relative Strength Index (14 RSI): | 57.48 | Buy |
Chaikin Money Flow: | 328463 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.66 - 12.66) | Buy |
Bollinger Bands (100): | (9.97 - 14.05) | Buy |
Nurix Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nurix Therapeutics Stock
Is Nurix Therapeutics Stock a Buy?
-
Nurix Therapeutics share price is 12.69 while NRIX 8-day simple moving average is 12.59, which is a Buy signal.
-
The stock price of NRIX is 12.69 while Nurix Therapeutics 20-day SMA is 12.06, which makes it a Buy.
-
Nurix Therapeutics 50-day simple moving average is 11.26 while NRIX share price is 12.69, making it a Buy technically.
-
NRIX stock price is 12.69 and Nurix Therapeutics 200-day simple moving average is 16.95, creating a Sell signal.
NRIX Technical Analysis vs Fundamental Analysis
Buy
66
Nurix Therapeutics (NRIX)
is a Buy
Is Nurix Therapeutics a Buy or a Sell?
-
Nurix Therapeutics stock is rated a BuyThe current Nurix Therapeutics [NRIX] share price is $12.69. The Score for NRIX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Nurix Therapeutics Stock Info
Market Cap:
970.1M
Price in USD:
12.69
Share Volume:
995.5K
Nurix Therapeutics 52-Week Range
52-Week High:
29.56
52-Week Low:
8.18
Buy
66
Nurix Therapeutics (NRIX)
is a Buy
Nurix Therapeutics Share Price Forecast
-
What is the Nurix Therapeutics stock price today?The Nurix Therapeutics stock price is 12.69 USD today.
-
Will NRIX stock go up or go down?Nurix Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nurix Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nurix Therapeutics is not overvalued.
Is Nurix Therapeutics Stock a Buy?
-
Nurix Therapeutics share price is 12.69 while NRIX 8-day exponential moving average is 9.04, which is a Buy signal.
-
The stock price of NRIX is 12.69 while Nurix Therapeutics 20-day EMA is 4.98, which makes it a Buy.
-
Nurix Therapeutics 50-day exponential moving average is 2.29 while NRIX share price is 12.69, making it a Buy technically.
-
NRIX stock price is 12.69 and Nurix Therapeutics 200-day simple moving average is 0.62, creating a Buy signal.
Fundamental Analysis of Nurix Therapeutics
Is Nurix Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.19 per share, and a decrease next year of $0.69 per share.
Technical Analysis of Nurix Therapeutics
Should I short Nurix Therapeutics stock?
-
NRIX Moving Average Covergence Divergence (MACD) indicator is 3.12, suggesting Nurix Therapeutics is a Buy
-
Nurix Therapeutics Relative Strength Index (RSI) is 57.48, which suggest Nurix Therapeutics is overbought
-
The Bollinger Bands (25) for Nurix Therapeutics is (11.66 - 12.66), which suggest Nurix Therapeutics is a Buy
-
The Bollinger Bands (100) for Nurix Therapeutics is (9.97 - 14.05), which suggest Nurix Therapeutics is a Buy
* Nurix Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.